Dr. Michael J. Reardon is a native Houstonian who attended Baylor College of Medicine where he graduated with honors and as a member of AOA. He did his general surgery residency under Dr. Michael DeBakey and cardiothoracic residency under Dr. Denton Cooley. He joined the staff of the Houston Methodist Hospital in 1985 and ran a private practice until 1993. He then joined the full-time faculty of BCM rising to Professor of Surgery with tenure, Chief of Cardiothoracic Surgery and Director of the thoracic residency program. He subsequently joined the academic group at the HMH as Professor of Cardiothoracic Surgery and Chief of Cardiac Surgery. He met his wife, Robin, in 1969 at Bellaire High School in Houston and married her in 1975. They have 2 daughters and 4 grandchildren.

He has served on multiple hospital committees and as elected president of the medical staff for the HMH and received numerous awards including the Overstreet Award and George Noon Award. He currently holds the position of Professor of Cardiothoracic Surgery and Allison Family Distinguished Chair of Cardiovascular Research and divides his time between building innovative clinical, research and educational programs.

His clinical and research interests have centered on aortic surgery, cardiac valve surgery and cardiac tumors. His recent research and clinical interests have focused on minimally invasive, catheter-based approaches to these areas. He serves on the national steering committee for the CoreValve, SurTAVI, Evolut Low-Risk,  Reprise III, Acurate, Navitor, Vantage and Envision TAVR trials and as national surgical PI on the SurTAVI, reprise III, Acurate, Navitor TAVR trials. He serves as the national chair of the Evolut low risk bicuspid, Vantage and Envision TAVR trials. He is the national PI for the J Valve EFS and national chair for the Journey IDE J valve trial. In the mitral space he serves on the executive steering committee and as co-chair if the screening committee for the Apollo trial. He is the national chair and on the executive committee for the Cephea trial. He is on the national steering committee and co-chair of the screening committee for the Medtronic tricuspid TTVR .In the aortic space he is national PI for Reprise I the Gore type A EFS dissection trial and the national chair of Reprise III the type A dissection IDE trial.

He holds the position of Clinical Professor of Cardiothoracic Surgery at MD Anderson Cancer Center and created the multi-institution, multidisciplinary cardiac tumor team with HMH and MDA. He has operated on more primary cardiac sarcomas than any other surgeon globally and has written extensively on this topic. Dr. Reardon's group recently published the largest series of surgically treated primary cardiac sarcomas in the world. Surgical Treatment of Primary Cardiac Sarcomas: Review of a Single-Institution Experience PMID 26476808. The HMH cardiac tumor database has produced over 50 publications.

Dr. Reardon conducts peer reviews for publications such as the Annals of Thoracic Surgery, Journal of Thoracic and Cardiothoracic Surgery, The New England Journal of Medicine,  Circulation, Journal of the American College of Cardiology and many others. He is the associate editor of surgery for the Methodist DeBakey Cardiovascular Journal. He has published over 1,000 peer reviewed papers, published abstracts and invited chapters and books. He has given over 1,000 invited presentations from over 6 continents.